ProCE Banner Activity

ExpressPoints: Current Landscape and Future Perspectives on NSCLC Biomarkers for Precision Medicine

Slideset Download
Download this short summary slideset of key takeaways from a live CCO Webinar on testing for and leveraging biomarkers critical to optimal use of targeted therapy and immunotherapy in the treatment of NSCLC.

Released: September 11, 2020

Expiration: September 10, 2021

No longer available for credit.

Share

Faculty

Matthew Gubens

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

Sanjay Mukhopadhyay

Sanjay Mukhopadhyay, MD

Director, Pulmonary Pathology
Department of Pathology
Cleveland Clinic
Cleveland, Ohio

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

Sanjay Mukhopadhyay, MD

Director, Pulmonary Pathology
Department of Pathology
Cleveland Clinic
Cleveland, Ohio